Historial de carrera de Jeffrey Molldrem
Antiguos cargos conocidos de Jeffrey Molldrem.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
The Vaccine Co.
 The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Director/Miembro de la Junta | 01/01/2003 | - |
| Fundador | 01/11/2009 | - | |
| Corporate Officer/Principal | 01/07/2003 | 01/11/2009 |
Formación de Jeffrey Molldrem.
| University of Minnesota | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
Operativa
| Director/Board Member | 1 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 2 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
The Vaccine Co.
The Vaccine Co. BiotechnologyHealth Technology The Vaccine Co. develops therapeutic vaccines for the treatment of leukemias and other types of cancers. Its products include Proteinase 3 PR1 peptide vaccine, Proteinase 3 PR1 peptide vaccine, and Myelodysplastic Syndrome. The company was founded by Jeffrey Molldrem, Ronald B. Garren, Gregory C. Thayer, and Craig S. Rosenfeld in 2003 and is headquartered in San Francisco, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey Molldrem
- Experiencia
